https://ir.castlebiosciences.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/castlebiosciences/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.castlebiosciences.com/news-events/press-releases/detail/481/new-decision-modeling-study-demonstrates-tissuecypher-significantly-improves-risk-aligned-management-for-patients-with-barretts-esophagus Tue, 15 Sep 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/481/new-decision-modeling-study-demonstrates-tissuecypher-significantly-improves-risk-aligned-management-for-patients-with-barretts-esophagus https://ir.castlebiosciences.com/news-events/press-releases/detail/480/jaad-publication-shows-improved-performance-of-decisiondx-scc Wed, 09 Sep 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/480/jaad-publication-shows-improved-performance-of-decisiondx-scc https://ir.castlebiosciences.com/news-events/press-releases/detail/479/castle-biosciences-to-participate-in-upcoming-investor-conferences Thu, 20 Aug 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/479/castle-biosciences-to-participate-in-upcoming-investor-conferences https://ir.castlebiosciences.com/news-events/press-releases/detail/478/castle-biosciences-approved-for-dual-listing-on-nasdaq-texas Mon, 17 Aug 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/478/castle-biosciences-approved-for-dual-listing-on-nasdaq-texas https://ir.castlebiosciences.com/news-events/press-releases/detail/477/castle-biosciences-reports-second-quarter-2026-results Thu, 30 Jul 26 16:05:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/477/castle-biosciences-reports-second-quarter-2026-results https://ir.castlebiosciences.com/news-events/press-releases/detail/476/castle-biosciences-to-present-at-the-canaccord-genuity-46th-annual-growth-conference Wed, 22 Jul 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/476/castle-biosciences-to-present-at-the-canaccord-genuity-46th-annual-growth-conference https://ir.castlebiosciences.com/news-events/press-releases/detail/475/castle-biosciences-announces-new-york-state-department-of-health-approval-of-its-advancead-tx-test Tue, 14 Jul 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/475/castle-biosciences-announces-new-york-state-department-of-health-approval-of-its-advancead-tx-test https://ir.castlebiosciences.com/news-events/press-releases/detail/474/castle-biosciences-to-release-second-quarter-2026-financial-results-and-host-webcast-on-thursday-july-30-2026 Thu, 09 Jul 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/474/castle-biosciences-to-release-second-quarter-2026-financial-results-and-host-webcast-on-thursday-july-30-2026 https://ir.castlebiosciences.com/news-events/press-releases/detail/473/decisiondx-melanomas-i31-slnb-outperforms-mia-nomogram-in-identifying-patients-who-may-safely-forgo-sentinel-lymph-node-biopsy Thu, 25 Jun 26 16:30:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/473/decisiondx-melanomas-i31-slnb-outperforms-mia-nomogram-in-identifying-patients-who-may-safely-forgo-sentinel-lymph-node-biopsy https://ir.castlebiosciences.com/news-events/press-releases/detail/472/castle-biosciences-chief-financial-officer-frank-stokes-named-a-2026-cfo-awards-honoree-by-the-houston-business-journal Tue, 23 Jun 26 07:00:00 -0400 https://ir.castlebiosciences.com/news-events/press-releases/detail/472/castle-biosciences-chief-financial-officer-frank-stokes-named-a-2026-cfo-awards-honoree-by-the-houston-business-journal